Chiome Bioscience Inc. [4583.T]
TOKYO, May 01 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) reported the exercise status for its 23rd tranche subscription rights with adjustment clause for April 2026.
A total of 1,808,000 shares were delivered during the month, representing 13.29% of the issuance total. As of the end of March 2026, there were 90,125 unexercised units remaining out of the initial 9,012,500 shares. During April, the company observed various exercise rates and prices. On April 1, 2,000 shares were exercised at ¥94.80 per share.
Other notable days included April 6, where 455 shares were transferred at ¥94.80, and April 24, which saw 1,000 shares transferred at ¥93. By the end of April, the number of unexercised units dropped to 72,045. The company adhered to the exercise limitations set forth by the Tokyo Stock Exchange's Article 434 of the Listing Rules and the Securities Association’s regulations on third-party allotments. The overall exercise ratio remained within the limit of 2.66%.
This report provides insight into the ongoing management and utilization of the subscription rights, reflecting the company's commitment to transparency and regulatory compliance.
🟢 Confidence: High AI-translated content.